...PIK3CA mutations and/or HER2 amplification. This study reveals that, even among these sensitive cancers, the initial eff...
...PIK3CA).,Target gene expression indicated PI3K activation in carcinomas, but not in adenomas. No amino acid-changing mut...
...PIK3CA (p110α) mutations are implicated in hepatocellular carcinoma (HCC); and previous work has contributed to thorough...
...PIK3CA, TP53, CpG island methylator phenotype or chromosomal instability status (P⩽0.036). Microarray analysis similarly...
...PIK3CA, PIK3RA, and AKT1. NOTCH1 mutations were identified in 51.9 and 37.9 % of pediatric and adult patients, respectiv...
...PIK3CA mutation and HER2 (ERBB2) amplification within HER2-positive breast cancer during neoadjuvant therapy. We found t...
...PIK3CA, some of which are candidates for targeted therapies.
...PIK3CA, leading to the evolution of the treatment of mCRC to a more precision-based approach. As our understanding of re...
...PIK3CA molecular evaluation was performed with RT-PCR and Sequenom.,From 165 deemed adequate by the pathologist pairs, 8...
...PIK3CA mutations are the predictive markers for anti-EGFR antibodies, trastuzumab, and lapatinib. The p110 isoform selec...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
